{"id":3980,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:02:12","modified_gmt":"2026-02-17T10:02:12","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/cs\/andromedic-esho-2014\/","title":{"rendered":"Evropsk\u00e1 spole\u010dnost pro hypertermickou onkologii\u00a0 ESHO 2014 &#8211; Andromedic intervence"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/cs\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/cs\/andromedic-esho-2014\/\",\n      \"name\": \"Klinick\u00e9 studie s Andromedic HyDeep 600 WM - Kongres ESHO\",\n      \"description\": \"Data z klinick\u00fdch studi\u00ed syst\u00e9mu HyDeep 600 WM pro karcinom d\u011blo\u017en\u00edho \u010d\u00edpku a multicentrick\u00e9 studie proveditelnosti prezentovan\u00e9 na kongresu ESHO.\",\n      \"inLanguage\": \"cs-CZ\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Studie LACC u karcinomu d\u011blo\u017en\u00edho \u010d\u00edpku\",\n          \"description\": \"Studie na 8 pacientech prokazuj\u00edc\u00ed 100% lok\u00e1ln\u00ed kontrolu p\u0159i pou\u017eit\u00ed syst\u00e9mu HyDeep 600 WM a HDR brachyterapie.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Rakovina d\u011blo\u017en\u00edho \u010d\u00edpku\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"P\u0159\u00edpadov\u00e1 studie ve \u0160pan\u011blsku\",\n          \"description\": \"Rozs\u00e1hl\u00e1 studie proveditelnosti s 293 pacienty zahrnuj\u00edc\u00ed 9 typ\u016f n\u00e1dor\u016f.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Pokro\u010dil\u00fd syst\u00e9m pro onkologickou hypertermii \/ profesion\u00e1ln\u00ed za\u0159\u00edzen\u00ed pro modulovanou RF hypertermii (13,56 MHz) pro lok\u00e1ln\u00ed hlubokou hypertermii.\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/cs\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Cena na vy\u017e\u00e1d\u00e1n\u00ed\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"\u0160pi\u010dkov\u00e1 technologie pro hlubokou hypertermii s klinicky ov\u011b\u0159en\u00fdmi protokoly.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">European Society for Hyperthermic Oncology: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Intervence spole\u010dnosti Andromedic \u2013 Dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">Na kongresu <a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a> ozn\u00e1mil <a href=\"https:\/\/andromedichyperthermia.com\/cs\/doctor-salvatore-conte\/\"><strong>Dr. Salvatore Conte<\/strong><\/a> v\u00fdznamn\u00fd miln\u00edk pro t\u00fdm Andromedic: \u00fasp\u011b\u0161nou v\u00fdrobu a dod\u00e1n\u00ed 25 <a href=\"https:\/\/andromedichyperthermia.com\/cs\/pokrocile-hypertermicke-zarizeni\/\">syst\u00e9m\u016f hlubok\u00e9 lok\u00e1ln\u00ed hypertermie <strong>HyDeep 600WM<\/strong><\/a> b\u011bhem pouh\u00fdch 18 m\u011bs\u00edc\u016f, p\u0159i\u010dem\u017e dal\u0161\u00edch 40 jednotek je ur\u010deno pro Indii.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase;\">Prezentovan\u00e9 klinick\u00e9 studie: HyDeep 600 WM \u2013 pokro\u010dil\u00fd syst\u00e9m onkologick\u00e9 hypertermie<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Chemoradioterapie + Hypertermie + HDR Brachyterapie pro LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>C\u00cdLE:<\/strong> Zkoumat v\u00fdsledky kombinace t\u00fddenn\u00edho pod\u00e1v\u00e1n\u00ed cisplatinu a hlubok\u00e9 lok\u00e1ln\u00ed hypertermie s IMRT n\u00e1sledovanou brachyterapi\u00ed (BRT) u lok\u00e1ln\u011b pokro\u010dil\u00e9ho karcinomu d\u011blo\u017en\u00edho \u010d\u00edpku (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MATERI\u00c1LY A METODY:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n<li><strong>Skupina pacient\u016f:<\/strong> 8 pacientek (3 ve st\u00e1diu IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<li><strong>Protokol:<\/strong> 50,4 Gy na p\u00e1nevn\u00ed uzliny s SIB na GTV (celkem 61,8 Gy) ve 28 frakc\u00edch. D\u00e1vka BRT: 21 Gy ve 3 frakc\u00edch.<\/li>\n<li><strong>Soub\u011b\u017en\u00e1 terapie:<\/strong> T\u00fddenn\u00ed Cisplatina 40mg\/m\u00b2 + HT jednou t\u00fddn\u011b.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">V\u00ddSLEDKY A Z\u00c1V\u011aRY:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">DOSA\u017dENO 100% LOK\u00c1LN\u00cd KONTROLY. Nebyla pozorov\u00e1na \u017e\u00e1dn\u00e1 akutn\u00ed ani pozdn\u00ed toxicita stupn\u011b 3 a\u017e 4 souvisej\u00edc\u00ed s l\u00e9\u010dbou.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">&#8222;P\u0159id\u00e1n\u00ed hlubok\u00e9 lok\u00e1ln\u00ed hypertermie k chemoradioterapii p\u0159edstavuje slibnou novou strategii s vynikaj\u00edc\u00ed toleranc\u00ed.&#8220;<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Studie proveditelnosti (Case-Control) \u2013 hlubok\u00e1 lok\u00e1ln\u00ed hypertermie &#8211; Andalusie, \u0160pan\u011blsko<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>\u00davod:<\/strong> Prvn\u00ed klinick\u00e1 studie ve \u0160pan\u011blsku kombinuj\u00edc\u00ed hlubokou lok\u00e1ln\u00ed hypertermii se standardn\u00ed onkologickou l\u00e9\u010dbou v r\u00e1mci ve\u0159ejn\u00e9ho zdravotnictv\u00ed.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Design studie:<\/strong> Prospektivn\u00ed, case-control studie. Celkem 293 pacient\u016f (97 v aktivn\u00ed f\u00e1zi vs. 196 kontrol). 9 lokalizac\u00ed tumor\u016f.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Parametry l\u00e9\u010dby:<\/strong> 10 sezen\u00ed (2-3\/t\u00fdden), d\u00e9lka 1 hodina, v\u00fdkon 150W\u2013400W s vyu\u017eit\u00edm <strong>za\u0159\u00edzen\u00ed pro modulovanou RF hypertermii HyDeep 600WM<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">P\u0159edb\u011b\u017en\u00e1 data (podskupina 22 pacient\u016f):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li style=\"list-style-type: none;\">\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li><strong>Glioblastom (2c)<\/strong><\/li>\n<li><strong>Hlava a krk (7c)<\/strong><\/li>\n<li><strong>P\u0159edopera\u010dn\u00ed rektum (3c)<\/strong><\/li>\n<li><strong>Rakovina prsu (3c)<\/strong><\/li>\n<li><strong>Pl\u00edce (NSCLC &#8211; 11c)<\/strong><\/li>\n<li><strong>Prostata (4c)<\/strong><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li><strong>D\u011blo\u017en\u00ed \u010d\u00edpek a metast\u00e1zy<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81.2%<\/span><br \/>\n<strong>VYSOK\u00c1 TOLERANCE<\/strong><br \/>\n<small>Pacienti spokojeni nebo velmi spokojeni<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66.6%<\/span><br \/>\n<strong>NULOV\u00c1 TOXICITA<\/strong><br \/>\n<small>Nebyly hl\u00e1\u0161eny \u017e\u00e1dn\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>Z\u00c1V\u011aR:<\/strong> Hlubok\u00e1 lok\u00e1ln\u00ed hypertermie je provediteln\u00e1 v b\u011b\u017en\u00e9 p\u00e9\u010di ve\u0159ejn\u00fdch nemocnic bez mimo\u0159\u00e1dn\u00fdch zdroj\u016f. Spr\u00e1vn\u00fd v\u00fdb\u011br pacient\u016f zaji\u0161\u0165uje minim\u00e1ln\u00ed toxicitu (stupe\u0148 1).<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">St\u00e1hnout kompletn\u00ed protokol studie (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">V\u011bdeck\u00e9 postery a dokumentace ESHO<\/h3>\n<div id='gallery-1' class='gallery galleryid-3980 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/cs\/klinicky-vyzkum\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1326\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1326'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/cs\/klinicky-vyzkum\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1305\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1305'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/cs\/klinicky-vyzkum\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-1284\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-1284'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>European Society for Hyperthermic Oncology: ESHO 2014 Intervence spole\u010dnosti Andromedic \u2013 Dr. Salvatore Conte Na kongresu ESHO 2014 ozn\u00e1mil Dr. Salvatore Conte v\u00fdznamn\u00fd miln\u00edk pro t\u00fdm Andromedic: \u00fasp\u011b\u0161nou v\u00fdrobu a dod\u00e1n\u00ed 25 syst\u00e9m\u016f hlubok\u00e9 lok\u00e1ln\u00ed hypertermie HyDeep 600WM b\u011bhem pouh\u00fdch 18 m\u011bs\u00edc\u016f, p\u0159i\u010dem\u017e dal\u0161\u00edch 40 jednotek je ur\u010deno pro Indii. Prezentovan\u00e9 klinick\u00e9 studie: HyDeep 600&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17338,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-3980","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/pages\/3980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/comments?post=3980"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/pages\/3980\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/media\/17338"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/cs\/wp-json\/wp\/v2\/media?parent=3980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}